Medtide Inc. (HKG:3880)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Medical Labs & Research	570.09M	442.23M	336.77M	350.84M	282.14M
Medical Labs & Research Growth	28.91%	31.31%	-4.01%	24.35%	-
Total	570.09M	442.23M	336.77M	350.84M	282.14M
Total Growth	28.91%	31.31%	-4.01%	24.35%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States of America	330.80M	243.21M	114.79M	132.31M	99.55M
United States of America Growth	36.02%	111.86%	-13.24%	32.91%	-
Europe	86.15M	48.62M	62.59M	45.02M	42.72M
Europe Growth	77.20%	-22.33%	39.04%	5.37%	-
Mainland China	78.97M	94.58M	74.12M	101.43M	85.00M
Mainland China Growth	-16.50%	27.59%	-26.92%	19.33%	-
Japan	37.55M	31.19M	73.57M	55.16M	22.06M
Japan Growth	20.41%	-57.61%	33.39%	150.01%	-
Others	36.62M	24.64M	11.69M	16.93M	32.80M
Others Growth	48.60%	110.73%	-30.92%	-48.40%	-
Total	570.09M	442.23M	336.77M	350.84M	282.14M
Total Growth	28.91%	31.31%	-4.01%	24.35%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 8, 2026

Data Sources Report a data error